1,456 Shares in Agilent Technologies, Inc. (NYSE:A) Bought by BBR Partners LLC

BBR Partners LLC purchased a new stake in shares of Agilent Technologies, Inc. (NYSE:A) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,456 shares of the medical research company’s stock, valued at approximately $216,000.

A number of other hedge funds also recently bought and sold shares of the company. Cetera Investment Advisers increased its position in Agilent Technologies by 953.3% during the first quarter. Cetera Investment Advisers now owns 32,694 shares of the medical research company’s stock worth $4,757,000 after acquiring an additional 29,590 shares during the period. iA Global Asset Management Inc. grew its position in Agilent Technologies by 26.2% during the first quarter. iA Global Asset Management Inc. now owns 21,770 shares of the medical research company’s stock worth $3,168,000 after buying an additional 4,523 shares in the last quarter. Marshall Financial Group LLC bought a new position in Agilent Technologies during the second quarter valued at about $1,058,000. Van ECK Associates Corp raised its holdings in Agilent Technologies by 6.6% in the 3rd quarter. Van ECK Associates Corp now owns 2,976,905 shares of the medical research company’s stock valued at $442,011,000 after acquiring an additional 183,716 shares in the last quarter. Finally, AXA S.A. lifted its position in shares of Agilent Technologies by 32.3% in the 2nd quarter. AXA S.A. now owns 362,945 shares of the medical research company’s stock worth $47,049,000 after acquiring an additional 88,667 shares during the period. 87.42% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on A shares. StockNews.com lowered shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Tuesday. TD Cowen upped their price objective on Agilent Technologies from $153.00 to $160.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. Wells Fargo & Company began coverage on Agilent Technologies in a research report on Tuesday, August 27th. They set an “overweight” rating and a $157.00 target price for the company. Sanford C. Bernstein lowered their price target on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating on the stock in a research report on Tuesday. Finally, JPMorgan Chase & Co. cut their price objective on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a report on Tuesday. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and eight have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $143.40.

Agilent Technologies Stock Up 2.8 %

Shares of Agilent Technologies stock opened at $138.11 on Thursday. The business has a fifty day simple moving average of $137.72 and a 200 day simple moving average of $137.43. The stock has a market cap of $39.68 billion, a PE ratio of 28.65, a price-to-earnings-growth ratio of 5.91 and a beta of 1.07. The company has a quick ratio of 1.37, a current ratio of 1.78 and a debt-to-equity ratio of 0.36. Agilent Technologies, Inc. has a 12 month low of $124.10 and a 12 month high of $155.35.

Agilent Technologies Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 22nd. Stockholders of record on Tuesday, December 31st will be issued a $0.248 dividend. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.24. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $0.99 annualized dividend and a dividend yield of 0.72%. Agilent Technologies’s payout ratio is 20.54%.

Insider Activity at Agilent Technologies

In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of Agilent Technologies stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total value of $1,448,550.00. Following the transaction, the senior vice president now owns 40,011 shares of the company’s stock, valued at approximately $5,801,595. The trade was a 19.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 0.33% of the stock is owned by corporate insiders.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.